For: | Jamal MM, Yoon EJ, Vega KJ, Hashemzadeh M, Chang KJ. Diabetes mellitus as a risk factor for gastrointestinal cancer among American veterans. World J Gastroenterol 2009; 15(42): 5274-5278 [PMID: 19908334 DOI: 10.3748/wjg.15.5274] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v15/i42/5274.htm |
Number | Citing Articles |
1 |
Juhua Luo, Rowan Chlebowski, Simin Liu, Katherine A. McGlynn, Niyati Parekh, Donna L. White, Karen L. Margolis. Diabetes mellitus as a risk factor for gastrointestinal cancers among postmenopausal women. Cancer Causes & Control 2013; 24(3): 577 doi: 10.1007/s10552-012-9996-8
|
2 |
Bin Bao, Zhiwei Wang, Yiwei Li, Dejuan Kong, Shadan Ali, Sanjeev Banerjee, Aamir Ahmad, Fazlul H. Sarkar. The complexities of obesity and diabetes with the development and progression of pancreatic cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2011; 1815(2): 135 doi: 10.1016/j.bbcan.2010.11.003
|
3 |
S. Schlesinger, K. Aleksandrova, T. Pischon, M. Jenab, V. Fedirko, E. Trepo, K. Overvad, N. Roswall, A. Tjønneland, M.C. Boutron-Ruault, G. Fagherazzi, A. Racine, R. Kaaks, V.A. Grote, H. Boeing, A. Trichopoulou, M. Pantzalis, M. Kritikou, A. Mattiello, S. Sieri, C. Sacerdote, D. Palli, R. Tumino, P.H. Peeters, H.B. Bueno-de-Mesquita, E. Weiderpass, J.R. Quirós, R. Zamora-Ros, M.J. Sánchez, L. Arriola, E. Ardanaz, M.J. Tormo, P. Nilsson, B. Lindkvist, M. Sund, O. Rolandsson, K.T. Khaw, N. Wareham, R.C. Travis, E. Riboli, U. Nöthlings. Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort. Annals of Oncology 2013; 24(9): 2449 doi: 10.1093/annonc/mdt204
|
4 |
Emily Jane Gallagher, Derek LeRoith. Insulin, Insulin Resistance, Obesity, and Cancer. Current Diabetes Reports 2010; 10(2): 93 doi: 10.1007/s11892-010-0101-y
|
5 |
Jason Gurney, James Stanley, Andrea Teng, Jeremy Krebs, Jonathan Koea, Chunhuan Lao, Ross Lawrenson, Ineke Meredith, Dianne Sika-Paotonu, Diana Sarfati, Dylan A. Mordaunt. Cancer and diabetes co-occurrence: A national study with 44 million person-years of follow-up. PLOS ONE 2022; 17(11): e0276913 doi: 10.1371/journal.pone.0276913
|
6 |
Saidul Islam Nayan, Md Habibur Rahman, Md. Mehedi Hasan, Sheikh Md. Razibul Hasan Raj, Mohammad Ali Abdullah Almoyad, Pietro Liò, Mohammad Ali Moni. Network based approach to identify interactions between Type 2 diabetes and cancer comorbidities. Life Sciences 2023; 335: 122244 doi: 10.1016/j.lfs.2023.122244
|
7 |
Joanne W. Elena, Emily Steplowski, Kai Yu, Patricia Hartge, Geoffrey S. Tobias, Michelle J. Brotzman, Stephen J. Chanock, Rachael Z. Stolzenberg-Solomon, Alan A. Arslan, H. Bas Bueno-de-Mesquita, Kathy Helzlsouer, Eric J. Jacobs, Andrea LaCroix, Gloria Petersen, Wei Zheng, Demetrius Albanes, Naomi E. Allen, Laufey Amundadottir, Ying Bao, Heiner Boeing, Marie-Christine Boutron-Ruault, Julie E. Buring, J. Michael Gaziano, Edward L. Giovannucci, Eric J. Duell, Göran Hallmans, Barbara V. Howard, David J. Hunter, Amy Hutchinson, Kevin B. Jacobs, Charles Kooperberg, Peter Kraft, Julie B. Mendelsohn, Dominique S. Michaud, Domenico Palli, Lawrence S. Phillips, Kim Overvad, Alpa V. Patel, Leah Sansbury, Xiao-Ou Shu, Michael S. Simon, Nadia Slimani, Dimitrios Trichopoulos, Kala Visvanathan, Jarmo Virtamo, Brian M. Wolpin, Anne Zeleniuch-Jacquotte, Charles S. Fuchs, Robert N. Hoover, Myron Gross. Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Cancer Causes & Control 2013; 24(1): 13 doi: 10.1007/s10552-012-0078-8
|
8 |
Elizabeth A. Suarez, Carol E. Koro, Jennifer B. Christian, Alicia D. Spector, Andre B. Araujo, Sybil Abraham. Incretin-mimetic therapies and pancreatic disease: a review of observational data. Current Medical Research and Opinion 2014; 30(12): 2471 doi: 10.1185/03007995.2014.960515
|
9 |
Dagfinn Aune, Lars J. Vatten. Diabetes mellitus and the risk of gallbladder disease: A systematic review and meta-analysis of prospective studies. Journal of Diabetes and its Complications 2016; 30(2): 368 doi: 10.1016/j.jdiacomp.2015.11.012
|
10 |
Saikat Sen, Raja Chakraborty, Biplab De. Diabetes Mellitus in 21st Century. 2016; : 69 doi: 10.1007/978-981-10-1542-7_8
|
11 |
Wenbin Tan, Min Gao, Ning Liu, Guoan Zhang, Tong Xu, Wen Cui. Body Mass Index and Risk of Gallbladder Cancer: Systematic Review and Meta-Analysis of Observational Studies. Nutrients 2015; 7(10): 8321 doi: 10.3390/nu7105387
|
12 |
Luciane B. Ceretta, Gislaine Z. Réus, Gislaine T. Rezin, Giselli Scaini, Emílio L. Streck, João Quevedo. Brain energy metabolism parameters in an animal model of diabetes. Metabolic Brain Disease 2010; 25(4): 391 doi: 10.1007/s11011-010-9220-z
|
13 |
Joo-Hyun Park, Jung Yong Hong, Kyungdo Han, Young Suk Park, Joon Oh Park. Light-to-Moderate Alcohol Consumption Increases the Risk of Biliary Tract Cancer in Prediabetes and Diabetes, but Not in Normoglycemic Status: A Nationwide Cohort Study. Journal of Clinical Oncology 2022; 40(31): 3623 doi: 10.1200/JCO.22.00145
|
14 |
Norbert Hüser, Volker Aßfalg, Helmut Friess. The Pancreas. 2018; : 717 doi: 10.1002/9781119188421.ch94
|
15 |
Kuan‐Fu Liao, Shih‐Wei Lai, Chia‐Ing Li, Wen‐Chi Chen. Diabetes mellitus correlates with increased risk of pancreatic cancer: A population‐based cohort study in Taiwan. Journal of Gastroenterology and Hepatology 2012; 27(4): 709 doi: 10.1111/j.1440-1746.2011.06938.x
|
16 |
Dagfinn Aune, Teresa Norat, Lars J. Vatten. Body mass index, abdominal fatness and the risk of gallbladder disease. European Journal of Epidemiology 2015; 30(9): 1009 doi: 10.1007/s10654-015-0081-y
|
17 |
Hao Liu, Yong Zhang, Min Ai, Jun Wang, Bo Jin, Zhaowei Teng, Yansheng Wang, Li Li. Body Mass Index Can Increase the Risk of Gallbladder Cancer: A Meta-Analysis of 14 Cohort Studies. Medical Science Monitor Basic Research 2016; 22: 146 doi: 10.12659/MSMBR.901651
|
18 |
Jun Gu, Shiyan Yan, Baochan Wang, Feng Shen, Haixia Cao, Jiangao Fan, Yuqin Wang. Type 2 diabetes mellitus and risk of gallbladder cancer: a systematic review and meta‐analysis of observational studies. Diabetes/Metabolism Research and Reviews 2016; 32(1): 63 doi: 10.1002/dmrr.2671
|
19 |
Zhan-Ming Li, Zhao-Xia Wu, Bing Han, Yu-Qin Mao, Hui-Ling Chen, San-Feng Han, Jing-Lin Xia, Li-Shun Wang. The association between BMI and gallbladder cancer risk: a meta-analysis. Oncotarget 2016; 7(28): 43669 doi: 10.18632/oncotarget.9664
|
20 |
Xiaohui Qi, Ping He, Huayan Yao, Huanhuan Sun, Jiying Qi, Min Cao, Bin Cui, Guang Ning. Insulin therapy and biliary tract cancer: insights from real-world data. Endocrine Connections 2022; 11(3) doi: 10.1530/EC-21-0546
|
21 |
Marta Sandini, Oliver Strobel, Thomas Hank, Magdalena Lewosinska, Anna Nießen, Thilo Hackert, Markus W. Büchler, Simon Schimmack. Pre-operative dysglycemia is associated with decreased survival in patients with pancreatic neuroendocrine neoplasms. Surgery 2020; 167(3): 575 doi: 10.1016/j.surg.2019.11.007
|
22 |
Andreas E. Buchs, Barbara G. Silverman. Incidence of malignancies in patients with diabetes mellitus and correlation with treatment modalities in a large Israeli health maintenance organization: a historical cohort study. Metabolism 2011; 60(10): 1379 doi: 10.1016/j.metabol.2011.05.002
|
23 |
Raymond Ngai Chiu Chan, Teddy Tai Loy Lee, Oscar Hou In Chou, Jenny So, Cheuk To Chung, Edward Christopher Dee, Kenrick Ng, Pias Tang, Leonardo Roever, Tong Liu, Wing Tak Wong, Gary Tse, Sharen Lee. Risk Factors of Pancreatic Cancer in Patients With Type 2 Diabetes Mellitus: The Hong Kong Diabetes Study. Journal of the Endocrine Society 2022; 6(11) doi: 10.1210/jendso/bvac138
|
24 |
Jeng‐Yeou Chen, Wen‐Ko Chiou, Wei‐Ying Chou, Jen‐Der Lin. The impact of type 2 diabetes mellitus on mortality in hospitalized female cancer patients in Taiwan. Asia-Pacific Journal of Clinical Oncology 2016; 12(1) doi: 10.1111/ajco.12084
|
25 |
M. Buysschaert, S. Sadikot. Diabetes and cancer: A 2013 synopsis. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2013; 7(4): 247 doi: 10.1016/j.dsx.2013.08.001
|
26 |
P Eijgenraam, M M Heinen, B A J Verhage, Y C Keulemans, L J Schouten, P A van den Brandt. Diabetes type II, other medical conditions and pancreatic cancer risk: a prospective study in The Netherlands. British Journal of Cancer 2013; 109(11): 2924 doi: 10.1038/bjc.2013.629
|
27 |
Pikli Batabyal, Stephen Vander Hoorn, Christopher Christophi, Mehrdad Nikfarjam. Association of Diabetes Mellitus and Pancreatic Adenocarcinoma: A Meta-Analysis of 88 Studies. Annals of Surgical Oncology 2014; 21(7): 2453 doi: 10.1245/s10434-014-3625-6
|
28 |
Hong-Bo Ren, Tao Yu, Chao Liu, Yan-Qing Li. Diabetes mellitus and increased risk of biliary tract cancer: systematic review and meta-analysis. Cancer Causes & Control 2011; 22(6): 837 doi: 10.1007/s10552-011-9754-3
|
29 |
Shih‐Min Chen, Phan Thanh Phuc, Phung‐Anh Nguyen, Whitney Burton, Shwu‐Jiuan Lin, Weei‐Chin Lin, Christine Y. Lu, Min‐Huei Hsu, Chi‐Tsun Cheng, Jason C. Hsu. A novel prediction model of the risk of pancreatic cancer among diabetes patients using multiple clinical data and machine learning. Cancer Medicine 2023; 12(19): 19987 doi: 10.1002/cam4.6547
|
30 |
Joo-Hyun Park, Jung Yong Hong, Young Suk Park, Gunseog Kang, Kyungdo Han, Joon Oh Park. Association of prediabetes, diabetes, and diabetes duration with biliary tract cancer risk: A nationwide cohort study. Metabolism 2021; 123: 154848 doi: 10.1016/j.metabol.2021.154848
|
31 |
Shih-Wei Lai, Kuan-Fu Liao, Pei-Chun Chen, Pang-Yao Tsai, Dennis Paul Hsientang Hsieh, Ching-Chu Chen. Antidiabetes Drugs Correlate With Decreased Risk of Lung Cancer: A Population-Based Observation in Taiwan. Clinical Lung Cancer 2012; 13(2): 143 doi: 10.1016/j.cllc.2011.10.002
|
32 |
Kyu-Tae Han, Seungju Kim. Post-Diagnostic Statin Use Reduces Mortality in South Korean Patients with Dyslipidemia and Gastrointestinal Cancer. Journal of Clinical Medicine 2021; 10(11): 2361 doi: 10.3390/jcm10112361
|
33 |
Jason K. Sicklick, Michael D’Angelica, Yuman Fong. Sabiston Textbook of Surgery. 2012; : 1411 doi: 10.1016/B978-1-4377-1560-6.00054-8
|
34 |
Adedayo A. Onitilo, Jessica M. Engel, Ingrid Glurich, Rachel V. Stankowski, Gail M. Williams, Suhail A. Doi. Diabetes and cancer I: risk, survival, and implications for screening. Cancer Causes & Control 2012; 23(6): 967 doi: 10.1007/s10552-012-9972-3
|
35 |
DeAnna Henderson, Danielle Frieson, Jeffrey Zuber, Solomon S. Solomon. Metformin Has Positive Therapeutic Effects in Colon Cancer and Lung Cancer. The American Journal of the Medical Sciences 2017; 354(3): 246 doi: 10.1016/j.amjms.2017.05.006
|
36 |
Norbert Hüser, Volker Aßfalg, Helmut Friess. The Pancreas. 2023; : 982 doi: 10.1002/9781119876007.ch127
|
37 |
Paweł Piątkiewicz, Anna Czech. Glucose Metabolism Disorders and the Risk of Cancer. Archivum Immunologiae et Therapiae Experimentalis 2011; 59(3): 215 doi: 10.1007/s00005-011-0119-0
|
38 |
Qiwen Ben, Maojin Xu, Xiaoyan Ning, Jun Liu, Shangyou Hong, Wen Huang, Huagao Zhang, Zhaoshen Li. Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. European Journal of Cancer 2011; 47(13): 1928 doi: 10.1016/j.ejca.2011.03.003
|
39 |
Junhui Li, Gang Cao, Qingyong Ma, Han Liu, Wei Li, Liang Han. The bidirectional interation between pancreatic cancer and diabetes. World Journal of Surgical Oncology 2012; 10(1) doi: 10.1186/1477-7819-10-171
|
40 |
Hsueh-Chou Lai, I-Ju Tsai, Pei-Chun Chen, Chih-Hsin Muo, Jen-Wei Chou, Cheng-Yuan Peng, Shih-Wei Lai, Fung-Chang Sung, Shu-Yu Lyu, Donald E. Morisky. Gallstones, a cholecystectomy, chronic pancreatitis, and the risk of subsequent pancreatic cancer in diabetic patients: a population-based cohort study. Journal of Gastroenterology 2013; 48(6): 721 doi: 10.1007/s00535-012-0674-0
|
41 |
Hsueh-Chou Lai, Shih-Ni Chang, Che-Chen Lin, Ching-Chou Chen, Jen-Wei Chou, Cheng-Yuan Peng, Shih-Wei Lai, Fung-Chang Sung, Yu-Fen Li. Does diabetes mellitus with or without gallstones increase the risk of gallbladder cancer? Results from a population-based cohort study. Journal of Gastroenterology 2013; 48(7): 856 doi: 10.1007/s00535-012-0683-z
|
42 |
Lalith Singh, Kanagavali M., Maga Rija, Raja Manoharan. Management of a Suspected Case of Gallbladder Cancer with Individualised Homoeopathy: A Case Report. Homœopathic Links 2021; 34(04): 300 doi: 10.1055/s-0041-1740239
|
43 |
Kyu-Tae Han, Seungju Kim. Lipid-lowering drug adherence and combination therapy effects on gastrointestinal cancer in patients with dyslipidemia without diabetes: a retrospective cohort study in South Korea. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09250-8
|
44 |
Chun-Chih Chiu, Chin-Chou Huang, Yu-Chun Chen, Tzeng-Ji Chen, Ying Liang, Shing-Jong Lin, Jaw-Wen Chen, Hsin-Bang Leu, Wan-Leong Chan. Increased Risk of Gastrointestinal Malignancy in Patients with Diabetes Mellitus and Correlations with Anti-Diabetes Drugs: A Nationwide Population-based Study in Taiwan. Internal Medicine 2013; 52(9): 939 doi: 10.2169/internalmedicine.52.8276
|
45 |
Veronica Wendy Setiawan, Daniel O Stram, Jacqueline Porcel, Suresh T Chari, Gertraud Maskarinec, Loïc Le Marchand, Lynne R Wilkens, Christopher A Haiman, Stephen J Pandol, Kristine R Monroe. Pancreatic Cancer Following Incident Diabetes in African Americans and Latinos: The Multiethnic Cohort. JNCI: Journal of the National Cancer Institute 2019; 111(1): 27 doi: 10.1093/jnci/djy090
|
46 |
Roy G.P.J. de Jong, Paul J.H.L. Peeters, Andrea M. Burden, Marie L. de Bruin, Harm R. Haak, Ad A.M. Masclee, Frank de Vries, Maryska L.G. Janssen-Heijnen. Gastrointestinal cancer incidence in type 2 diabetes mellitus; results from a large population-based cohort study in the UK. Cancer Epidemiology 2018; 54: 104 doi: 10.1016/j.canep.2018.04.008
|